TAO WU to Antineoplastic Agents
This is a "connection" page, showing publications TAO WU has written about Antineoplastic Agents.
Connection Strength
0.355
-
An albumin-prodrug injectable formulation for synergistic cancer immunotherapy. J Colloid Interface Sci. 2025 May 15; 686:1019-1032.
Score: 0.115
-
Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia. J Clin Invest. 2020 02 03; 130(2):981-997.
Score: 0.082
-
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor. Cell. 2018 01 25; 172(3):578-589.e17.
Score: 0.071
-
Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo. Biomed Res Int. 2017; 2017:4101653.
Score: 0.068
-
Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG). Cancer Med. 2018 12; 7(12):5952-5961.
Score: 0.019